← 產業報告目錄
Prescription Digital Therapeutics (PDT) Market Size, Share & Trends Analysis Report By Type (Medication Augmentation, Medication Replacement), By Application (Children, Adults), By Software, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-11頁數 175報告編號 INSIGHTACE-250a7328e1
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Prescription Digital Therapeutics (PDT) Market stood at USD 4.41 billion in 2023, and is projected to reach USD 21.18 billion by 2031, recording a CAGR of 22.41% from 2024 through 2031.
The Prescription Digital Therapeutics (PDT) sector involves one type of prescription digital medicine that is used to treat a variety of ailments. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Prescription Digital Therapeutics (PDT) Market Snapshot
Chapter 4. Global Prescription Digital Therapeutics (PDT) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Medication Augmentation
5.2.2. Medication Replacement
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Children
6.2.2. Adults
Chapter 7. Market Segmentation 3: by Software Estimates & Trend Analysis
7.1. by Software & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Software:
7.2.1. Software for Respiratory Conditions
7.2.2. Software for Mental Health
7.2.3. Software for Opioid Use Disorder
7.2.4. Software for Diabetes
7.2.5. Others
Chapter 8. Market Segmentation 4: by Services Estimates & Trend Analysis
8.1. by Services & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Services:
8.2.1. Behavioral Microservices
8.2.2. Medical Microservices
Chapter 9. Prescription Digital Therapeutics (PDT) Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.1.2. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.1.3. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.1.4. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.1.5. North America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.2.2. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.3. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.2.4. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.2.5. Europe Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.3.2. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.3. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.3.4. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.3.5. Asia Pacific Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.4.2. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.3. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.4.4. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.4.5. Latin America Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.5.2. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.3. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Software, 2024-2031
9.5.4. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by Services, 2024-2031
9.5.5. Middle East & Africa Prescription Digital Therapeutics (PDT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Akili Interactive
10.2.2. Pear Therapeutics
10.2.3. Better Therapeutics
10.2.4. ResMed
10.2.5. Biofourmis
10.2.6. Novartis
10.2.7. Medtronic
10.2.8. Voluntis
10.2.9. Omada Health
10.2.10. GAIA
10.2.11. Solera Network
10.2.12. BigHealth
10.2.13. Click Therapeutics
10.2.14. Happify
10.2.15. Limbix Health
10.2.16. Naturalcycles Nordic
10.2.17. NuvoAir
10.2.18. Sensyne Health
10.2.19. Xealth
10.2.20. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們